Insider trading

Period: 120 months Stock: NBIX + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

545 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

545 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

545 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

545 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
545 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
545 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

545 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
13 Jun 2018
Grigoriadis Dimitri E. Chief Research Officer
Sold, plan not stated 2×
$8.37M 84,178 at 99.46
50.4%
Sold half or more
13 Jun 2018
LYONS GARY A Director
Sold, plan not stated
$1.49M 15,000 at 99.24
5.4%
11 Jun 2018
Sold, plan not stated
$984.42K 10,000 at 98.44
17.4%
1 Jun 2018
BENEVICH ERIC Chief Commercial Officer
Sold, plan not stated
$1.20M 12,350 at 97.34
42.5%
7 May 2018
Sold, plan not stated
$415.63K 5,000 at 83.13
10.4%
1 May 2018
GORMAN KEVIN CHARLES Chief Executive Officer
Sold, plan not stated
$10.24M 126,832 at 80.75
26.8%
5 Mar 2018
Bozigian Haig P. Chief Development Officer
Sold, plan not stated 2×
$6.83M 75,873 at 90.00
35.8%
5 Mar 2018
Gano Kyle Chief Business Development Off
Sold, plan not stated
$2.13M 23,650 at 90.00
23.1%
5 Mar 2018
Lippoldt Darin Chief Legal Officer
Sold, plan not stated
$175.09K 1,979 at 88.47
11.0%
15 Feb 2018
LYONS GARY A Director
Sold, plan not stated
$423.34K 5,000 at 84.67
1.9%
12 Feb 2018
Grigoriadis Dimitri E. Chief Research Officer
Sold, plan not stated
$1.17M 14,593 at 80.00
15.0%
9 Feb 2018
Grigoriadis Dimitri E. Chief Research Officer
Sold, plan not stated
$5.60M 71,775 at 77.98
46.4%
6 Feb 2018
GORMAN KEVIN CHARLES Chief Executive Officer
Sold, plan not stated
$8.01M 100,000 at 80.07
22.6%
5 Feb 2018
GORMAN KEVIN CHARLES Chief Executive Officer
Sold, plan not stated 2×
$498.16K 5,983 at 83.26
1.7%
5 Feb 2018
LYONS GARY A Director
Sold, plan not stated
$415.38K 5,000 at 83.08
1.8%
5 Feb 2018
Lippoldt Darin Chief Legal Officer
Sold, plan not stated 2×
$227.49K 2,737 at 83.12
17.2%
5 Feb 2018
OBrien Christopher Flint Former Chief Medical Officer
Sold, plan not stated 2×
$217.34K 2,613 at 83.18
4.8%
5 Feb 2018
Bozigian Haig P. Chief Development Officer
Sold, plan not stated 2×
$187.98K 2,262 at 83.10
1.7%
5 Feb 2018
Grigoriadis Dimitri E. Chief Research Officer
Sold, plan not stated 2×
$170.00K 2,046 at 83.09
2.5%
5 Feb 2018
Gano Kyle Chief Business Development Off
Sold, plan not stated 2×
$169.91K 2,046 at 83.05
2.6%
5 Feb 2018
Lloyd-Smith Malcolm Chief Regulatory Officer
Sold, plan not stated
$79.86K 960 at 83.19
6.4%
5 Feb 2018
BENEVICH ERIC Chief Commercial Officer
Sold, plan not stated
$68.17K 820 at 83.14
24.1%
24 Jan 2018
Sold, plan not stated
$855.00K 9,500 at 90.00
27.7%
16 Jan 2018
GORMAN KEVIN CHARLES Chief Executive Officer
Sold, plan not stated
$295.82K 3,750 at 78.89
1.1%
16 Jan 2018
OBrien Christopher Flint Chief Medical Officer
Sold, plan not stated
$138.50K 1,750 at 79.14
3.3%
16 Jan 2018
Bozigian Haig P. Chief Development Officer
Sold, plan not stated
$128.57K 1,625 at 79.12
1.2%
16 Jan 2018
Grigoriadis Dimitri E. Chief Research Officer
Sold, plan not stated
$128.56K 1,625 at 79.12
2.0%
16 Jan 2018
Gano Kyle Chief Business Development Off
Sold, plan not stated
$128.46K 1,625 at 79.05
2.1%
3 Jan 2018
Lippoldt Darin Chief Legal Officer
Sold, plan not stated
$157.05K 1,979 at 79.36
13.1%
2 Jan 2018
Lloyd-Smith Malcolm Chief Regulatory Officer
Sold, plan not stated
$1.40M 18,084 at 77.52
58.1%
Sold half or more
28 Dec 2017
Lippoldt Darin Chief Legal Officer
Sold, plan not stated
$1.14M 15,237 at 75.00
53.7%
Sold half or more
8 Dec 2017
Lippoldt Darin Chief Legal Officer
Sold, plan not stated
$221.63K 2,955 at 75.00
18.3%
4 Dec 2017
Lippoldt Darin Chief Legal Officer
Sold, plan not stated
$471.16K 6,279 at 75.04
32.3%
1 Dec 2017
LYONS GARY A Director
Sold, plan not stated
$729.18K 10,000 at 72.92
3.5%
15 Nov 2017
Lippoldt Darin Chief Legal Officer
Sold, plan not stated
$723.19K 9,900 at 73.05
42.9%
8 Nov 2017
Grigoriadis Dimitri E. Chief Research Officer
Sold, plan not stated
$2.24M 30,000 at 74.58
27.9%
2 Nov 2017
OBrien Christopher Flint Chief Medical Officer
Sold, plan not stated 2×
$3.68M 52,817 at 69.71
51.9%
Sold half or more
2 Nov 2017
Gano Kyle Chief Business Development Off
Sold, plan not stated 2×
$1.76M 24,818 at 71.05
25.3%
2 Oct 2017
OBrien Christopher Flint Chief Medical Officer
Sold, plan not stated
$422.70K 6,925 at 61.04
12.4%
6 Sep 2017
Bozigian Haig P. Chief Development Officer
Sold, plan not stated 2×
$1.58M 26,250 at 60.00
16.8%
6 Sep 2017
Gano Kyle Chief Business Development Off
Sold, plan not stated 2×
$1.50M 25,000 at 60.00
25.4%
6 Sep 2017
Lippoldt Darin Chief Legal Officer
Sold, plan not stated
$6.00K 100 at 60.00
0.8%
5 Sep 2017
OBrien Christopher Flint Chief Medical Officer
Sold, plan not stated
$3.04M 52,817 at 57.50
51.9%
Sold half or more
9 Aug 2017
Grigoriadis Dimitri E. Chief Research Officer
Sold, plan not stated
$844.47K 15,354 at 55.00
12.5%
9 Aug 2017
Lippoldt Darin Chief Legal Officer
Sold, plan not stated
$275.00K 5,000 at 55.00
27.5%
4 Aug 2017
Bozigian Haig P. Chief Development Officer
Sold, plan not stated 2×
$1.13M 22,500 at 50.00
14.8%
27 Jul 2017
OBrien Christopher Flint Chief Medical Officer
Sold, plan not stated
$436.70K 8,734 at 50.00
15.1%
23 May 2017
Grigoriadis Dimitri E. Chief Research Officer
Sold, plan not stated
$533.90K 10,000 at 53.39
8.5%
19 May 2017
Lloyd-Smith Malcolm Chief Regulatory Officer
Sold, plan not stated
$268.92K 4,980 at 54.00
27.7%
18 May 2017
OBrien Christopher Flint Chief Medical Officer
Sold, plan not stated
$5.63M 105,634 at 53.32
68.3%
Sold half or more
Showing 451–500 of 545. ← Newer Page 10 of 11 Older →